BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 30208168)

  • 21. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
    Velazquez Torres A; Gariglio Vidal P
    Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence.
    Speel EJ
    Recent Results Cancer Res; 2017; 206():57-72. PubMed ID: 27699529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Replication Stress in Human Papillomavirus Pathogenesis.
    Moody CA
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why Human Papillomaviruses Activate the DNA Damage Response (DDR) and How Cellular and Viral Replication Persists in the Presence of DDR Signaling.
    Bristol ML; Das D; Morgan IM
    Viruses; 2017 Sep; 9(10):. PubMed ID: 28934154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus E6/E7 oncoproteins promote radiotherapy-mediated tumor suppression by globally hijacking host DNA damage repair.
    Bruyere D; Roncarati P; Lebeau A; Lerho T; Poulain F; Hendrick E; Pilard C; Reynders C; Ancion M; Luyckx M; Renard M; Jacob Y; Twizere JC; Peiffer R; Peulen O; Delvenne P; Hubert P; McBride A; Gillet N; Masson M; Herfs M
    Theranostics; 2023; 13(3):1130-1149. PubMed ID: 36793865
    [No Abstract]   [Full Text] [Related]  

  • 26. Relationship between vaginal microecological changes and oncogene E6/E7 and high-risk human papillomavirus infection.
    Huang J; Yin C; Wang J
    J Obstet Gynaecol; 2023 Dec; 43(1):2161349. PubMed ID: 36645341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro.
    Slebos RJ; Kessis TD; Chen AW; Han SM; Hedrick L; Cho KR
    Virology; 1995 Apr; 208(1):111-20. PubMed ID: 11831691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA damage response is hijacked by human papillomaviruses to complete their life cycle.
    Hong SY
    J Zhejiang Univ Sci B; 2017 Mar; 18(3):215-232. PubMed ID: 28271657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current advances in the mechanic studies of human papillomavirus-induced oncogenesis].
    Zhou XB; Xu NZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):673-7. PubMed ID: 18051727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinogenesis Associated with Human Papillomavirus Infection. Mechanisms and Potential for Immunotherapy.
    Vonsky M; Shabaeva M; Runov A; Lebedeva N; Chowdhury S; Palefsky JM; Isaguliants M
    Biochemistry (Mosc); 2019 Jul; 84(7):782-799. PubMed ID: 31509729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genomic organization and proteins of human papillomavirus].
    Alp Avcı G
    Mikrobiyol Bul; 2012 Jul; 46(3):507-15. PubMed ID: 22951665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
    Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
    J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Papillomavirus E6 proteins.
    Howie HL; Katzenellenbogen RA; Galloway DA
    Virology; 2009 Feb; 384(2):324-34. PubMed ID: 19081593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Centrosome abnormalities and genomic instability induced by human papillomavirus oncoproteins.
    Duensing S; Münger K
    Prog Cell Cycle Res; 2003; 5():383-91. PubMed ID: 14593733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation.
    Mittal S; Banks L
    Mutat Res Rev Mutat Res; 2017; 772():23-35. PubMed ID: 28528687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic instability and cancer: lessons learned from human papillomaviruses.
    Korzeniewski N; Spardy N; Duensing A; Duensing S
    Cancer Lett; 2011 Jun; 305(2):113-22. PubMed ID: 21075512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
    Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
    Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections.
    von Knebel Doeberitz M
    Eur J Cancer; 2002 Nov; 38(17):2229-42. PubMed ID: 12441259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fanconi anemia pathway limits human papillomavirus replication.
    Hoskins EE; Morreale RJ; Werner SP; Higginbotham JM; Laimins LA; Lambert PF; Brown DR; Gillison ML; Nuovo GJ; Witte DP; Kim MO; Davies SM; Mehta PA; Butsch Kovacic M; Wikenheiser-Brokamp KA; Wells SI
    J Virol; 2012 Aug; 86(15):8131-8. PubMed ID: 22623785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosomal gains and losses in human papillomavirus-associated neoplasia of the lower genital tract - a systematic review and meta-analysis.
    Thomas LK; Bermejo JL; Vinokurova S; Jensen K; Bierkens M; Steenbergen R; Bergmann M; von Knebel Doeberitz M; Reuschenbach M
    Eur J Cancer; 2014 Jan; 50(1):85-98. PubMed ID: 24054023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.